Higashiyama RI, Yoshida T, Yagishita S, Hamada A, et al. In Response: Letter Received From Dr. Charles Ricordel Titled "Safety of Extended-Interval Dosing Strategy of Immune Checkpoint Inhibitors for Advanced NSCLC". J Thorac Oncol 2023;18:e16-e17.
PMID: 36682843